NCT00003832View on ClinicalTrials.gov

Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

June 30, 2002

Conditions
Stage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Interventions
DRUG

bromodeoxyuridine

Given IV

PROCEDURE

conventional surgery

Undergo surgery

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

80217-3364

University of Colorado, Denver

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003832 - Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer | Biotech Hunter | Biotech Hunter